JUDEEN BURKE: Open Payments
NPI 1639651326 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,150 in 124 payments from 44 companies in 2025. Trend: 2023 $263 · 2024 $1,063 · 2025 $4,150
Food & beverage: $2,890Long term medical supply or device loan: $798Education: $462
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $1,027 |
| SEAGEN INC. | 2 | $199 |
| Merck Sharp & Dohme LLC | 8 | $175 |
| Genmab U.S., Inc. | 2 | $166 |
| Daiichi Sankyo Inc. | 4 | $158 |
| AstraZeneca Pharmaceuticals LP | 3 | $143 |
| Janssen Biotech, Inc. | 6 | $142 |
| SOBI, INC | 3 | $141 |
| JAZZ PHARMACEUTICALS INC. | 5 | $135 |
| Fennec Pharmaceuticals, Inc. | 2 | $126 |
Products named: KISQALI, KEYTRUDA, ZEPZELCA, Enhertu, Cellsearch, Lenvima, VERZENIO, XT CDX.
Industry payments across FL — which companies pay providers there.
